CJC-1295 (No DAC) vs Tesamorelin

Two GHRH analogues compared. Here is how the two research peptides compare on class, format and price.

CJC-1295 (No DAC)

CJC-1295 without DAC (Mod GRF 1-29) is a synthetic analogue of growth-hormone-releasing hormone. It is supplied lyophilised in a 10 mg vial for laboratory and in-vitro research use only.

CJC-1295 (No DAC) is studied for GHRH-receptor signalling and is frequently researched alongside the GHRP peptide Ipamorelin, with which it is often combined.

Tesamorelin

Tesamorelin is a synthetic analogue of growth-hormone-releasing hormone. It is supplied lyophilised in a 10 mg vial for laboratory and in-vitro research use only.

Tesamorelin is studied for GHRH-receptor signalling in metabolic and growth-hormone research, and sits alongside CJC-1295 in the GHRH-analogue class.

Which do researchers choose?

CJC-1295 (No DAC) and Tesamorelin are two GHRH analogues compared. The right choice depends on the research question: they differ in class (Mod GRF (1-29) GHRH analogue vs GHRH analogue) and strength (10 mg vs 10 mg). Both are supplied lyophilised, third-party HPLC tested, and shipped express post Australia-wide for laboratory and in-vitro research use only.

Frequently asked questions